You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for Patent: 11,060,093


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,060,093 protect, and when does it expire?

Patent 11,060,093 protects OXLUMO and is included in one NDA.

This patent has twenty-nine patent family members in eighteen countries.

Summary for Patent: 11,060,093
Title:Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
Abstract: This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Inventor(s): Brown; Bob D. (Cambridge, MA), Dudek; Henryk T. (Cambridge, MA)
Assignee: Dicerna Pharmaceuticals, Inc. (Lexington, MA)
Application Number:16/545,149
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 11,060,093

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alnylam Pharms Inc OXLUMO lumasiran sodium SOLUTION;SUBCUTANEOUS 214103-001 Nov 23, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (PH1) ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,060,093

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3581654 ⤷  Sign Up LUC00218 Luxembourg ⤷  Sign Up
European Patent Office 3581654 ⤷  Sign Up PA2021008 Lithuania ⤷  Sign Up
European Patent Office 3581654 ⤷  Sign Up 301132 Netherlands ⤷  Sign Up
European Patent Office 3581654 ⤷  Sign Up 2021C/534 Belgium ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.